Shopping Cart
Remove All
Your shopping cart is currently empty
14,15-Epoxyeicosatrienoic acid (14,15-EET), derived from Arachidonic acid metabolism, significantly inhibits platelet aggregation in vivo and enhances astrocytic Aβ clearance, making it relevant for Alzheimer's Disease research [1][2].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 8-10 weeks |
| Description | 14,15-Epoxyeicosatrienoic acid (14,15-EET), derived from Arachidonic acid metabolism, significantly inhibits platelet aggregation in vivo and enhances astrocytic Aβ clearance, making it relevant for Alzheimer's Disease research [1][2]. |
| In vitro | 14,15-Epoxyeicosatrienoic acid (0-10 μM) enhances Aβ uptake in primary astrocyte cultures [1]. |
| In vivo | 14,15-Epoxyeicosatrienoic acid (0.3 mg/kg i.v.) inhibits platelet aggregation in murine cerebral arterioles [2]. Administration of 14,15-Epoxyeicosatrienoic acid (200 ng/ml) into the hippocampus reverses Aβ deposition in the brains of 6-month-old male FAD mice [1]. |
| Synonyms | 14,15-EET |
| Molecular Weight | 320.47 |
| Formula | C20H32O3 |
| Cas No. | 81276-03-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.